Glenn W. Welling
Engaged Capital
Glenn W. Welling BioDelivery Sciences International Inc stake
total: 101
Engaged Capital BDSI trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2016 Q1
- Held for:
- 4 quarters
- Latest activity:
- 2017 Q1
According to 2026 Q2 report, Glenn W. Welling doesn't hold any BioDelivery Sciences International Inc (BDSI) shares. To date, the estimated cost basis is nearly $3.23 for "buy" trades and estimated average "sell" price is $1.75. Engaged Capital first purchased BDSI in 2016 Q1, initially acquiring about 1.88M shares. Since the initial investment in BioDelivery Sciences International Inc (BDSI), Engaged Capital has made 2 more transactions.
When did Glenn W. Welling sell BioDelivery Sciences International Inc (BDSI)?
Glenn W. Welling sold off the entire BioDelivery Sciences International Inc (BDSI) position in 2017 Q1.
When did Glenn W. Welling buy BioDelivery Sciences International Inc (BDSI)?
Glenn W. Welling first invested in BioDelivery Sciences International Inc (BDSI) in 2016 Q1 at the reported quarter-end price of $3.23 per share.
What's the cost basis of Engaged Capital's BDSI stake?
The estimated cost basis for BioDelivery Sciences International Inc (BDSI) stake is around $3.23 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $3.23
- Weighted AVG sell price:
- $1.75
Glenn W. Welling's historical trades in BioDelivery Sciences International Inc
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.